Chen T L, Li J M, Ye T V, Cone C M, Feldman D
J Cell Physiol. 1986 Jan;126(1):21-8. doi: 10.1002/jcp.1041260104.
The level of 1,25(OH)2D3 receptors in cultured mouse osteoblast-like (OB) cells is modulated by the rate of cell proliferation. We have studied two 1,25(OH)2D3-induced bioresponses to ascertain whether the changes in receptor levels during growth in culture alter cell responsiveness. Nuclear receptor levels were high (127 fmol/100 micrograms DNA) in rapidly dividing (log) cells and low (25 fmol/100 micrograms DNA) in quiescent (confluent) cells. The bioresponses we studied were induction of 25(OH)D3-24-hydroxylase activity (24-hydroxylase) and inhibition of collagen synthesis. The basal levels of 24-hydroxylase were low and similar in cells at log growth phase and confluence. At a maximal induction dose of 13 nM, 1,25(OH)2D3 induced a three-fold rise in enzyme activity at long growth phase, but only caused less than two-fold rise at confluence. The half-maximal dose (ED50) was slightly shifted from 0.6 nM to 0.8 nM. Daily measurement of 1,25(OH)2D3 receptor levels and maximal induction of 24-hydroxylase activity throughout the culture cycle showed a strong correlation between receptor abundance and enzyme induction. The basal level of collagen synthesized by cells in log growth phase was approximately 5% and increased to approximately 8% at confluence. Maximal inhibition of collagen synthesis by 1,25(OH)2D3 reached 80% of control levels in log cells, but was only 40% of control in confluent cells. The ED50 was approximately 0.1 nM in the log cells and increased to approximately 1 nM at confluence. Daily assay of 1,25(OH)2D3 receptor levels and 1,25(OH)2D3 responses during the culture cycle indicated a correlation between changes in receptor level and the extent of inhibition of collagen synthesis. These changes in bioresponse at various growth phases did not occur in rat OB cells where the 1,25(OH)2D3 receptor levels were independent of cell proliferation. The results indicate that cell proliferation rate, via change in receptor levels, determines the magnitude and sensitivity of the cellular responses to 1,25(OH)2D3.
培养的小鼠成骨细胞样(OB)细胞中1,25(OH)₂D₃受体的水平受细胞增殖速率的调节。我们研究了两种1,25(OH)₂D₃诱导的生物反应,以确定培养过程中受体水平的变化是否会改变细胞反应性。在快速分裂(对数期)的细胞中,核受体水平较高(127 fmol/100微克DNA),而在静止(汇合)细胞中较低(25 fmol/100微克DNA)。我们研究的生物反应是25(OH)D₃-24-羟化酶活性(24-羟化酶)的诱导和胶原蛋白合成的抑制。24-羟化酶的基础水平在对数生长期细胞和汇合细胞中较低且相似。在最大诱导剂量13 nM时,1,25(OH)₂D₃在对数生长期诱导酶活性增加三倍,但在汇合时仅引起不到两倍的增加。半数最大剂量(ED₅₀)从0.6 nM略微移至0.8 nM。在整个培养周期中每天测量1,25(OH)₂D₃受体水平和24-羟化酶活性的最大诱导,结果显示受体丰度与酶诱导之间存在很强的相关性。对数生长期细胞合成的胶原蛋白基础水平约为5%,汇合时增加到约8%。1,25(OH)₂D₃对胶原蛋白合成的最大抑制在对数期细胞中达到对照水平的80%,但在汇合细胞中仅为对照的40%。ED₅₀在对数期细胞中约为0.1 nM,汇合时增加到约1 nM。在培养周期中每天检测1,25(OH)₂D₃受体水平和1,25(OH)₂D₃反应,结果表明受体水平变化与胶原蛋白合成抑制程度之间存在相关性。在1,25(OH)₂D₃受体水平与细胞增殖无关的大鼠OB细胞中,各个生长阶段的这些生物反应变化并未发生。结果表明,细胞增殖速率通过受体水平的变化,决定了细胞对1,25(OH)₂D₃反应的幅度和敏感性。